Although not reaching statistical significance, there was a favorable trend toward slowed global VF MD progression after supplementation began, suggesting a possible neuroprotective effect.
← all excerpts
Next-Gen Neuroprotection in Glaucoma: Synergistic Molecules for Targeted Therapy.
2
—
—
The sentences
Mixed-model crossover analysis confirmed a highly significant treatment effect on both N35–P50 and P50–N95 amplitudes with no evidence of carryover.